Ultragenyx Pharmaceutical Inc. (RARE) is drawing attention in the biotechnology space as multiple late-stage programs advance toward pivotal readouts. With a diversified pipeline targeting rare and ultra-rare genetic diseases, the company is positioned at a critical stage where upcoming trial results and regulatory decisions may chart the next stage of its journey.Company Overview• Founded in 2010...
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.